Comparison between Nectar Lifesciences IPO and Provogue IPO.
Nectar Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Provogue IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Nectar Lifesciences IPO | Provogue IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ICICI Securities Ltd. | Anand Rathi Advisors Ltd. Karvy Investor Services Ltd. SBI Capital Markets Ltd. |
| Registrar | Kfin Technologies Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Nectar Lifesciences IPO is up to ₹92.88 Cr whereas the issue size of the Provogue IPO is up to ₹60.74 Cr. The final issue price of Nectar Lifesciences IPO is ₹240.00 per share and of Provogue IPO is ₹150.00 per share.
| Nectar Lifesciences IPO | Provogue IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹200.00 per share | ₹130.00 per share |
| Issue Price (Upper) | ₹240.00 per share | ₹150.00 per share |
| Issue Price (Final) | ₹240.00 per share | ₹150.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 38,70,000 shares | 40,49,402 shares |
| Fresh Issue Size (Amount) | up to ₹92.88 Cr | up to ₹60.74 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,70,000 shares | 40,49,402 shares |
| Issue Size Total (Amount) | up to ₹92.88 Cr | up to ₹60.74 Cr |
Nectar Lifesciences IPO opens on Jun 22, 2005, while Provogue IPO opens on Jun 10, 2005. The closing date of Nectar Lifesciences IPO and Provogue IPO is Jun 28, 2005, and Jun 16, 2005, respectively.
Nectar Lifesciences IPO P/E ratio is , as compared to Provogue IPO P/E ratio of .
| Nectar Lifesciences IPO | Provogue IPO | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.08 | 68.49 | ||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.93 | 51.37 | ||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 31.3 | 15.83 | ||||||||||||||||||||||||||||||||||||||||||||
In the Nectar Lifesciences IPO Retail Individual Investors (RII) are offered 13,54,500 shares while in Provogue IPO retail investors are offered 13,54,500 shares. Qualified Institutional Buyers (QIB) are offered 19,35,000 shares in Nectar Lifesciences IPO and 20,24,701 shares in Provogue IPO.
| Nectar Lifesciences IPO | Provogue IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 19,35,000 shares | 20,24,701 shares |
| NII | 5,80,500 shares | 6,07,410 shares |
| RII | 13,54,500 shares | 14,17,291 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 38,70,000 shares | 40,49,402 shares |
Nectar Lifesciences IPO subscribed in total, whereas Provogue IPO subscribed .
